Transcatheter Interventions Online 2022 - On Demand

Published: 09 March 2022

  • Views:

    Views Icon 46267
  • Likes:

    Heart Icon 7
  • episode_image
    1h 2m 19s
    Part 1 | Session 2 Session 1.2: Live Cases and Discussion Lars Søndergaard, Ole De Backer, Holger Thiele, Nicolas M Van Mieghem, Azeem Latib, Kendra J Grubb, David Hildick-Smith, Mohamed Abdel-Wahab
  • episode_image
    57m 43s
    Part 2 | Session 2 Session 2.2: Live Cases and Discussion George D Dangas, Holger Thiele, Ajay J Kirtane, Joost Daemen, Margaret McEntegart, Azeem Latib, Didier Tchétché, Annapoorna Kini
  • episode_image
    56m 37s
    Part 2 | Session 5 Session 2.4: Live Cases and Discussion Roxana Mehran, David Hildick-Smith, Holger Thiele, Nicolas M Van Mieghem, Ajay J Kirtane, Margaret McEntegart, Roberto Diletti
  • episode_image
    59m 54s
    Part 3 | Session 2 Session 3.3: Live Cases and Discussion Roxana Mehran, Nicolas M Van Mieghem, Kendra J Grubb, David Hildick-Smith, Lars Søndergaard, Philipp Lurz, Joost Daemen, Christian Besler
  • episode_image
    1h 3m 33s
    Part 3 | Session 4 Session 3.4: Debates Nicolas M Van Mieghem, Ajay J Kirtane, Roxana Mehran, Philipp Lurz
Average (ratings)
No ratings
Your rating

Overview

Following on from the success of 2021's inaugural edition, Transcatheter Interventions Online 2022  brings together a world-class faculty to provide expert insight and educational learning on the latest developments in interventional management.
 

Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2022 delivers best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.

 

Note, the live version of this session was CME accredited; this on-demand version is not.

 

 

 

 

Transcatheter Interventions Online 2022 was supported by the following partners:

Key Learning Objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation

Target Audience

  • Interventional Cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional Cardiology Nurses

More from this programme

Faculty Biographies

Felix Mahfoud

Felix Mahfoud

Professor of Cardiology and Chairman of the Department of Cardiology

Prof Felix Mahfoud is a Professor of Cardiology at the University of Basel and the Chairman of the Department of Cardiology at University Hospital Basel, Switzerland. He also holds a position as Visiting Professor at Harvard-MIT, Biomedical Engineering in Boston, MA. 

Prof Mahfoud is board-certified in internal medicine, cardiology, intensive care medicine, emergency medicine and hypertension. He is Deputy Editor of the European Journal of Heart Failure and is a Councillor on the Board of the European Society of Cardiology (ESC) for 2024-2026. Additionally, he chairs both the ESC Communication Committee and the Scientific Documents Committee of the EAPCI for the 2024-2026 term. 

He has published more than 500 publications in peer-reviewed journals and contributed as a wiring committee member to the 2019 ESC Guidelines for the…

View full profile
Andrew SP Sharp

Andrew SP Sharp

Professor of Cardiology

Prof Andrew Sharp is a Professor of Cardiology at the University College Dublin and The Mater Misericordiae Hospital, Dublin, IE. Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in Cardiff in the summer of 2019.

Andrew conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the prestigious Milan-Imperial Interventional Cardiology Fellowship programme. Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, pulmonary embolism, intracoronary imaging and coronary physiology.

Andrew's specialist interests include the…

View full profile
Roland E Schmieder

Roland E Schmieder

Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension

Roland E Schmieder is a Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension at the University Hospital Erlangen, Germany. He also directs the Institute of Preventative Medicine at the University Erlangen-Nuremberg and the Community Hospital Nuremberg. Roland is a member of numerous professional societies and committees, and is a Fellow of the American College of Physicians (ACP) and the American College of Cardiology (ACC). He is on the international Editorial Board of the American Journal of Hypertension, the Journal of Human Hypertension and the Journal of Nephrology, among other scientific journals. Professor Schmieder received his post-graduate medical training in nephrology, cardiology and hypertension at the University Hospital of Bonn, and then at the Alton Ochsner Foundation, New Orleans. He graduated in medicine from the…

View full profile